Good news in the world’s flu fight: One dose of the new swine flu vaccine looks strong enough to protect adults — and can spark protection within 10 days of the shot, Australian and U.S. researchers said Thursday.
Tens of thousands of health care workers who typically avoid flu shots are under more pressure than ever to get vaccinated as hospitals and clinics prepare for a spike in swine flu cases this fall and winter.
Approved the first vaccine against swine flu, Panflu, is ahead of its Western competitors not only in speed but in price and composition. It is manufactured in China and the manufacturing company, Sinovac, said to be safe and effective.
During the swine flu pandemic there will still be myocardial infarction, appendicitis, cardiac failure, diabetes, asthma attack, psychiatry diseases, hip fractures, accidents and thousands of other illness that require medical attention. It is important that patients suffering from swine flu do not panic and overwhelm the system, so hospitals and doctors can continue to treat all patients.
For that, it is essential to keep calm and have common sense and self-control in all levels, patients, health professionals, decision makers, politicians and the media.
The answer may be at hand to a crucial question about vaccination for the advancing swine flu — one shot or two? Chinese officials approved a vaccine Thursday that they say prevents the new flu in a single dose.